[Form 3] Tempus AI, Inc. Initial Statement of Beneficial Ownership
Rhea-AI Filing Summary
Tempus AI, Inc. executive Thomas Edward Schoenherr, CEO of Diagnostics, reported beneficial ownership of 94,967 shares of Class A common stock in an initial insider filing. This amount includes 54,405 restricted stock units, which vest in scheduled installments through February 15, 2028, and 20,000 shares certified as earned from performance-based stock units granted on August 7, 2025. The performance-based units are scheduled to vest on August 15, 2026 after the board certified achievement of the required performance metrics on February 20, 2026.
Positive
- None.
Negative
- None.
Insider Trade Summary
1 transaction reported
Mixed
1 txn
Insider
Schoenherr Thomas Edward
Role
CEO, Diagnostics
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| holding | Class A Common Stock | -- | -- | -- |
Holdings After Transaction:
Class A Common Stock — 94,967 shares (Direct)
Footnotes (1)
- F1. Includes (i) 54,405 restricted stock units ("RSUs"), of which 27,180 RSUs vest on each of February 15, 2027 and February 15, 2028 and 15 RSUs vest on each of April 15, 2026, July 15, 2026 and October 15, 2026, and (ii) 20,000 shares certified as earned with respect to an award of performance-based stock units ("PSUs") granted on August 7, 2025. The Issuer's Board of Directors certified the achievement of the applicable performance metrics and goals on February 20, 2026 and the PSUs will vest, in accordance with their terms, on August 15, 2026.
AI-generated analysis. How Rhea-AI works. Not financial advice.